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Systemic bile acid (BA) homeostasis is a critical
determinant of dietary fat digestion, enterohepatic
function, and postprandial thermogenesis. However,
major checkpoints for the dynamics and the molec-
ular regulation of BA homeostasis remain unknown.
Here we show that hypothalamic-pituitary-adrenal
(HPA) axis impairment in humans and liver-specific
deficiency of the glucocorticoid receptor (GR) in
mice disrupts the normal changes in systemic BA
distribution during the fasted-to-fed transition.
Fasted mice with hepatocyte-specific GR knock-
down had smaller gallbladder BA content and were
more susceptible to developing cholesterol gall-
stones when fed a cholesterol-rich diet. Hepatic GR
deficiency impaired liver BA uptake/transport via
lower expression of themajor hepatocyte basolateral
BA transporter, Na+-taurocholate transport protein
(Ntcp/Slc10a1), which affected dietary fat absorption
and brown adipose tissue activation. Our results
demonstrate a role of the HPA axis in the endocrine
regulation of BA homeostasis through the liver GR
control of enterohepatic BA recycling.
INTRODUCTION
In mammals, systemic bile acid (BA) homeostasis during the
fasting-feeding cycle is a critical determinant of dietary fat diges-
tion as well as gastrointestinal hormone secretion (Trauner and
Boyer, 2003). BA also have an important signaling function in
liver metabolism (Watanabe et al., 2004) as well as negative-
feedback regulation of their own synthesis (Sinal et al., 2000)
through the intracellular nuclear BA receptor farnesoid
X receptor (FXR). Furthermore, BA can also affect metabolism
in peripheral tissues by acting through a cell-surface G protein
coupled receptor TGR5 to stimulate mitochondrial uncouplingand thermogenesis in brown adipose tissue (BAT) (Watanabe
et al., 2006). Indeed, altered systemic BA handling affects meta-
bolic regulation in humans (Kars et al., 2010), and thus it is
increasingly recognized that altering endogenous BA handling
or administration of exogenous BA (derivatives) has therapeutic
potential to treat metabolic diseases (Thomas et al., 2008).
Throughout the daily feeding-fasting transition, BA are re-
cycled from the bloodstream back to the gallbladder after
a meal via trans-hepatic transport mechanisms. Moreover,
95% of BA are recycled via enterohepatic transport (Trauner
and Boyer, 2003), the remainder of which is replaced via de
novo synthesis from cholesterol by regulatory feedback loops
that are predominantly controlled by the intrahepatic liver X
receptor (LXR)/FXR nuclear receptor network (Sinal et al., 2000).
The hypothalamic-pituitary-adrenal (HPA) endocrine axis is an
important physiological stress circuit to maintain homeostasis of
multiple systems during trauma, exercise, or fasting/starvation
(Rose et al., 2010). In the liver, adrenal glucocorticoids control
gluconeogenesis and triglyceride handling through the glucocor-
ticoid receptor (GR), a member of the nuclear receptor transcrip-
tion factor family (Opherk et al., 2004) (Lemkeet al., 2008). Intrigu-
ingly, we (Lemke et al., 2008) and others (Zollner and Trauner,
2009) previously observed that the hepatic GR also regulates
genes involved in liver cholesterol and BAmetabolism, the phys-
iological relevance of which remained unclear. To examine
a previously undefined role of the liver GR in the regulation of
cholesterol and bile acid homeostasis we used in vivo liver- and
hepatocyte-specific gene knockdown strategies in mice.RESULTS
Liver GR Affects Systemic BA Homeostasis
and Cholesterol Gallstone Development
To explore a possible connection between the hepaticGRandBA
homeostasis, we abrogated hepatic GR function in mice by liver-
specificGRknockdown (Lemkeetal., 2008) in the fastedand refed
state (FiguresS1AandS1B), leading toelevatedserumcorticoste-
rone levels and fastinghypoglycemia (Opherket al., 2004) (Figures
S1C and S1D). In control animals, feeding increased serum BA
levels 8- to 10-fold as compared with the fasted state (Figure 1A).Cell Metabolism 14, 123–130, July 6, 2011 ª2011 Elsevier Inc. 123
Figure 1. Liver Glucocorticoid Receptor Deficiency Disrupts Systemic Bile Acid Homeostasis
(A–F) Serum (A), liver (B), intestine (C), and gallbladder (GB) bile, (D), bile acid (BA) levels in fasted or refed male C57BL/6J mice treated with PBS (n = 4), negative
control (NC; n = 8), or GR-specific (n = 8) shRNA adenovirus. Systemic BA distribution was calculated (E). In (F), BA levels in serum samples were collected from
individuals with Addison’s disease following acute treatment withdrawal as well as matched healthy control individuals before (time 0) and after consuming
a nutrient-rich meal (n = 9).
(G–J) Serum BA (G), GB BA content (I), and cholesterol saturation index (CSI) (J) in fasted mice on a lithogenic (Lith) or matched control (Con) diet for 14 days. (H)
Intact GBs from mice fed Lith diet.
(K–R) male C57L/J mice treated with negative control (NC) or GR-specific miRNA adeno-associated virus were placed on a Lith or Con diet for 6 wk (n = 11–12)
and analyzed for GB bile acid content (K), volume (L), CSI (O), and serum BA levels (M) in the fasted state. (N) Serum BA levels (N) in wild-type (WT) and
hepatocyte-specific GR knockout mice (GRAlfpCre) under normal chow fed conditions (n = 4). (P) representative polarizing light micrographs of GB bile indicative of
number of cholesterol crystals per unit volume of bile from same animals as in (K-R). (Q-R) Cholesterol crystals (Q) and gallstones (R) in GB bile in same animals as
in (K-R).
(S–U) SerumBA (S), GB bile volume (T), and cholesterol crystals (U) in Lith or Con diet-fed C57L/Jmice treated daily with Dex (1mg/kg) or vehicle (Veh) for 14 days
(n = 7-8). Data are mean ± SEM. *, difference between shRNA/miRNA/genotype; #, difference between treatment; y, interaction between shRNA and diet,
p < 0.05. Also see Figure S1.
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Hepatic GR Controls Bile Acid HomeostasisDespite fasting hyperglucocorticoidemia (Figure S1C), serum
BA levels in mice with liver GR deficiency were much higher
than in the control mice during fasting and there was no further
increase in the refed condition (Figure 1A). Furthermore, hepatic
GR knockdown significantly blunted the feeding-induced
increases in liver (Figure 1B) and intestinal (Figure 1C) BA levels,
accompaniedbyamarkedly reducedgallbladderBAamount (Fig-
ure 1D) under both fasted and fed conditions, despite no alter-
ations in gallbladder BA concentration (Figure S1E). Along with
mostly unaltered effects on fecal BA output (Figure S1F) and
liver-damage markers (Figure S1G), mice with liver-specific GR
deficiency had an overall aberrant systemic BA distribution both
in the fasted and fed state (Figure 1E). These results indicated
that there is an aberrant regulation of systemic BA homeostasis
with liver GR deficiency. Importantly, the disturbed systemic BA
handling was recapitulated in human patients with HPA axis defi-
ciency (i.e., Addison’s disease) (Figure 1F).
Since we observed an effect on liver BA levels and total
gallbladder BA, we next tested whether short-term liver GR
knockdown affects gallbladder bile cholesterol solubility. To
this end, we challenged mice with shRNA-mediated liver GR
knockdown (Figures S1H and S1I) with a lithogenic diet, which
increases liver cholesterol load (Figure S1J) and induces choles-
terol gallstone disease in susceptible mice after prolonged treat-
ment. Liver GR knockdown in C57BL/6J mice resulted in higher
fasting serum BA, which was exacerbated in mice on the litho-
genic diet (Figure 1G) along with lower gallbladder volume
(Figures 1H and S1K) and thus total gallbladder BA (Figure 1I).
In combination with unaltered levels of gallbladder bile choles-
terol (Figure S1L) and phospholipids (Figure S1M), the abroga-
tion of the lithogenic diet-dependent increase in gallbladder BA
concentration (Figure S1N) resulted in a significant decrease in
bile cholesterol solubility with liver GR knockdown (Figure 1J),
indicative of heightened susceptibility to cholesterol gallstone
formation (Wang et al., 2009). We next sought to examine
whether liver GR deficiency impacts upon cholesterol gallstone
formation by using a more long-term model of hepatocyte-
specific GR knockdown in gallstone susceptible C57L/J mice.
To this end, we employed a novel adeno-associated virus
(AAV) delivery system allowing the expression of inhibitory
miRNAs specifically in liver parenchymal cells but not in other
liver cell types for a period of several months. Eight weeks after
AAV delivery, mice with hepatocyte-specific GR knockdown
(Figures S1O–S1Q) that did not affect liver damagemarkers (Fig-
ure S1R) displayed significantly lower amounts of BA in gallblad-
ders (Figure 1K), lower gallbladder bile volume (Figure 1L), and
higher levels of serumBA (Figure 1M), especially on the lithogenic
diet. These effects could not be explained by enhanced intestinal
BA absorption as there was greater fecal loss of BA (Figure S1S).
Importantly, an 9-fold elevation of serum BA levels (Figure 1N)
was also observed in animals lacking hepatocyte expression
of the GR due to Cre/LoxP-mediated genetic gene knockout
(Figure S1T) (Opherk et al., 2004). While there was an expected
fasting hypoglycemia (Figure S1U), but no differences in liver
(Figure S1V) and serum (Figure S1W) cholesterol levels,
miRNA-mediated hepatocyte-specific deficiency in GR caused
gallbladder bile cholesterol supersaturation (Figure 1O), as deter-
mined by a higher ratio of cholesterol to BA (Figure S1X). Indeed,
hepatocyte-specific knockdown of the GR triggered greater bilecholesterol crystallization under both control and lithogenic die-
tary conditions in C57L/J mice (Figures 1P and 1Q), which ulti-
mately resulted in greater number of mice with visible gallstones
ascomparedwith controlmiRNA-injected littermates (Figure 1R).
Reflecting the reduction of hepatic BA content with GR defi-
ciency (Figure 1B), a prototypical target gene (i.e., Shp) of the
nuclear BA receptor, FXR (Sinal et al., 2000), was downregulated
in GR-deficient livers (Figures S1Y–S1AA), leading to a compen-
satory induction of the BA synthesis genes Cyp7a1 (Figures
S1AB–S1AD) and Cyp8b1 (Figures S1AE–S1AF).
Given the consistent effects of liver GC/GR deficiency on
systemic BA regulation, we next tested the consequences of
pharmacological GR activation on BA homeostasis. To this
end, we administered the specific GR agonist dexamethasone
(Dex) in combination with lithogenic diet feeding to gallstone-
susceptible mice. Dex-treated mice displayed lower serum BA
levels (Figure 1S) and higher gallbladder bile volume (Figure 1T),
which culminated in lower cholesterol crystallization in gall-
bladder bile (Figure 1U), indicative of a protective effect of GR
agonism on the development of cholesterol gallstone formation.
Liver GR Action Affects Liver Bile Acid
Uptake/Transport via Ntcp
We next hypothesized that the accumulation of BA in the serum
of fasted mice with liver GR deficiency (Figure 1) may be due to
defective liver transport of BA across the basolateral membrane
of hepatocytes. Indeed, the 2-fold upregulation of maximal
ex vivo liver BA uptake with fasting was absent in liver
GR-deficient mice (Figure 2A). Furthermore, maximal in vitro
BA transport was 50% lower in membrane vesicles prepared
from livers of fasted mice with hepatocyte-specific GR ablation
(Figure 2B). Consequently, we screened for mRNA expression
of the known liver BA transporters. Both, Na+-taurocholate
transport protein (Ntcp/Slc10a1) (Figures S2A–S2C) and multi-
drug resistance protein 2 (Mrp2/Abcc2) (Figures S2G–S2I) but
not other transporters such as Bsep, Mrp3, or Oatp1 (Figures
S2D–S2F and S2J–S2M) were consistently downregulated in
various models of liver GR deficiency. Furthermore, Ntcp protein
expression was reduced in all models of liver GR deficiency
investigated (Figure 2D–2F, S2B, and S2C). In congruence, treat-
ment with the GR agonist Dex had the opposite effect of GR
deficiency on Ntcp expression (Figure 2G).
Since the variability of maximal BA transport in livers of GR
knockdown mice could be largely attributed to Ntcp expression
(Figure S2N), we examined BA homeostasis in mice with liver-
specific Ntcp deficiency. Indeed, we observed that either partial
(40%) or near complete (80%) liver Ntcp deficiency
(Figure S2O) disrupted the normal entero-hepatic BA cycling
as evidenced by a greatly reduced liver BA transport (Figure 2H)
as well as repartitioning of BA in the serum (Figure 2I) and
gallbladder (Figure 2J) in fasted to fed transition.
The GR Affects Liver BA Handling by Direct
Transcriptional Activation of Ntcp
As the metabolic consequences of GR manipulation correlated
with altered Ntcp mRNA expression (Figures S2A–S2C), we
hypothesized that the GR acts via direct genomic action to affect
Ntcp gene transcription. An in vitro ABCDassay revealed that the
GR binds strongly to several regions of themurine Ntcp proximalCell Metabolism 14, 123–130, July 6, 2011 ª2011 Elsevier Inc. 125
Figure 2. Liver Bile Acid Transport and Slc10a1/Ntcp Expression Are Reduced in Mice with Liver GR Deficiency
(A and B) Ex vivo (A, n = 8) and in vitro (B, n = 9) bile acid (BA) uptake/transport in liver samples from mice as in Figure 1.
(C–G) Ntcp protein/mRNA expression in livers from mice treated as in Figure 1. Inserts in (C)-(F) are representative western blot images of Ntcp and vasolin-
containing protein (Vcp).
(H–J) Liver bile acid (BA) uptake (H), serum BA levels (I) and gallbladder bile volume (J) in C57BL/6Jmice treated with negative control (NC), low dose (53 108 ifu),
and normal dose (2 3 109 ifu) Ntcp-specific shRNA adenovirus under fasted or refed conditions (n = 5–6). Data are mean ± SEM. *, difference between shRNA/
miRNA/genotype/drug versus control; **, difference between shRNA/miRNA/genotype/drug versus all corresponding groups; # difference between diet, p < 0.05.
Also see Figure S2.
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Hepatic GR Controls Bile Acid Homeostasispromoter (Figure 3A). Furthermore, chromatin immunoprecipita-
tion assays demonstrated that the GRbinds to the Ntcp proximal
promoter in the livers of wild-type mice upon fasting in vivo
(Figures 3B and S3A), a condition of heightened Ntcp mRNA
expression (Figure S3B). Fasting also increased RNA
polymerase II binding to the proximal Ntcp promoter, which
was abrogated in mice with liver GR deficiency (Figure 3C).
Importantly, GR binding to the proximal promoter of the Ntcp
gene was also detectable in livers of humans (Figure S3C), and126 Cell Metabolism 14, 123–130, July 6, 2011 ª2011 Elsevier Inc.GC treatment was found to increase Ntcp expression in human
livers ex vivo in a GR-dependent manner (Figure S3D).
To verify the possible functional significance of GR DNA
binding to the Ntcp promoter in vivo, we examined mice
harboring a DNA binding-defective GR mutant (GRdim) that
leaves GR protein-protein interaction capacities intact. Litho-
genic diet-fed GRdim mice exhibited higher fasting serum BA
(Figure 3D), lower gallbladder bile volume (Figure 3E), completely
blunted glucocorticoid-stimulated Ntcp expression (Figures 3F
Figure 3. The DNA-Binding Function of the
GR Is Essential for Its Effects on Systemic
Bile Acid Homeostasis and Liver Ntcp
Expression
(A) Avidin-biotin complex DNA (ABCD) assays in
mouse liver extracts (n = 3) using glucocorticoid
response element (GRE), negative control (neg),
and 55 base pair oligonucleotides covering the
proximal mouse Ntcp promoter. Insert: represen-
tative western blot image.
(B and C) Chromatin immunoprecipitation (ChIP)
assay of liver extracts from fasted or refed mice
using antibodies specific for GR (B, n = 5) and RNA
polymerase II (C, n = 8). Precipitated DNA frag-
ments were analyzed using primers flanking the
proximal promoter of the mouse Ntcp gene as well
as negative control primers (TbpEx3). Data show
recruitment relative to negative control IgG and
chromatin input. *, difference compared with re-
fed; #, difference between shRNA treatment.
(D–G) Serum bile acids (BA) (D), gallbladder bile
volume (E), liver Ntcp protein expression (F), and
maximal BA transport (G) in fasted wild-type (WT)
andGRdimerization deficient (GRdim) mice treated
daily with dexamethasone (Dex; 1mg/kg) or
vehicle (Veh) as well as a lithogenic (Lith) diet for
12 days (n = 3–4). Data are mean ± SEM. *,
difference between genotype; #, difference
between diet; p < 0.05. Also see Figure S3.
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Hepatic GR Controls Bile Acid Homeostasisand S3E), and liver BA transport (Figure 3G) as compared with
wild-type littermates. Thus, DNA binding is required for the regu-
latory function of the GR on Ntcp gene expression and systemic
BA handling in vivo.
Extrahepatic Effects of Altered BA Homeostasis
with Liver GR Deficiency
BA is important for dietary lipid digestion/absorption and have
been also implicated in postprandial thermogenesis (Thomas
et al., 2008). Indeed, mice with liver GR deficiency gained less
weight over time, which was exacerbated by administration of
a diet containing BA (Figure 4A). Intestinal fat absorption was
defective in mice with liver GR deficiency as there was greater
fecal loss of triglycerides and nonesterified fatty acids in liver
GR knockdown experiments (Figures 4B, 4C, and S4A), which
could not be explained by differences in total fecal mass
(data not shown) nor altered intestinal BA transporter (Fig-
ure S4B) or Fgf15 (Figure S4C) expression. Furthermore, liverCell Metabolism 14, 123GR deficiency promoted greater thermo-
genic potential as exemplified by hyper-
activation of cAMP signaling in BAT
(Figures 4D and S4D) and higher thermo-
genic gene expression (Figures 4E, 4F,
and S4D–S4F).
DISCUSSION
Our results provide evidence of a direct
regulatory function of the hepatic GR for
Ntcp-mediated BA uptake and trans-hepatic BA flux throughout the fasting period, thereby ensuring
efficient BA recycling and gallbladder filling in preparation for
the next feeding cycle. This GR-dependent regulation of liver
BA handling is physiologically important since95% of BA is re-
cycled via enterohepatic transport (Trauner and Boyer, 2003).
Since we observed an effect on total gallbladder BA, we
hypothesized that liver GR knockdown would affect gallbladder
bile cholesterol solubility. This question was important as
cholesterol gallstone disease (CGD) is one of the most costly
and prevalent digestive diseases in developed countries and
although the etiology of CGD is typically multifactorial, the
main primary cause is chronic biliary hypersecretion of choles-
terol relative to BA and phospholipids, which eventually results
in cholesterol precipitation and crystallization (Wang et al.,
2009). In accordance with our hypothesis, hepatocyte deficiency
in GR culminated in a greater incidence of cholesterol gallstones,
indicating that the HPA-liver GR axis may have a protective func-
tion for CGD development.–130, July 6, 2011 ª2011 Elsevier Inc. 127
Figure 4. Extrahepatic Effects of Altered
Bile Acid Homeostasis with Liver GR Defici-
ency
(A–C) body mass (A, n = 11–12), fecal triglyceride
(B) and nonesterified fatty acid (NEFA, C) levels
(n = 6-7) in the same mice as in Figure 1.
(D–F) Phospho-Ser/Thr-protein kinase A sub-
strates (D), uncoupling protein 1 (Ucp1, E) and
deiodinase-2 (Dio2, F) mRNA levels in brown
adipose tissue (BAT) in mice treated as in Figure 1
(n = 5–6). Data are mean ± SEM. * , difference
between shRNA/miRNA treatment; #, difference
between diet; p < 0.05. Also see Figure S4.
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Hepatic GR Controls Bile Acid HomeostasisConceptually, the defective BA recycling from the serum to the
gallbladder with liver GR deficiency could be due to a defect in
transport at the hepatocyte basolateral or canalicular membrane
(Trauner and Boyer, 2003). However, since there was no
increase in intrahepatic BA upon feeding in liver GR-deficient
mice, our results provide a basis for a tight control of BA trans-
port by GR regulation of basolateral Ntcp. Indeed, the GR was
found to bind strongly to several regions of the Ntcp proximal
promoter in vitro, thereby validating previous in silico predictions
(Cheng et al., 2007). Consistent with previous in vitro studies
(Eloranta et al., 2006), we could show that ex vivo glucocorticoid
treatment of human liver increases Ntcp expression in a
GR-dependent manner, and that the GR binds and is required
for the binding of the transcriptional machinery, to the Ntcp prox-
imal promoter in the livers of mice upon fasting in vivo. Similar to
the other models of total liver GR deficiency and consistent with
direct GR DNA recruitment to the Ntcp promoter, lithogenic diet-
fed GRdim mice exhibited higher fasting serum BA and lower128 Cell Metabolism 14, 123–130, July 6, 2011 ª2011 Elsevier Inc.gallbladder bile volume and completely
blunted the previously described (Simon
et al., 2004) (Cheng et al., 2007) glucocor-
ticoid-stimulated Ntcp expression. This
supports the notion that GR dimerization
and subsequent direct DNA binding is
required for the molecular regulation of
increased Ntcp transcription by the GR,
thereby providing a molecular basis of
HPA-GC actions on liver BA transport
and systemic BA homeostasis in vivo.
In terms of functional significance, the
efficient recycling of BA via the upregula-
tion of liver BA transport and Ntcp
expression by the GR not only contrib-
utes to dietary lipid digestion/absorption
but may also prevent undesirable energy
wasting during fasting (Rothwell et al.,
1982) as BA can act as signaling mole-
cules to stimulate thermogenesis via
a GPCR-cAMP signaling pathway BAT
(Watanabe et al., 2006). Indeed, we
demonstrate here that the impaired liver
BA recycling with liver GR deficiency
correlated with higher BAT uncoupling
potential and heightened cAMP signal-
ing, perhaps explaining an earlier obser-vation that a disruption in the HPA-GC axis increases BAT
activity and systemic resting energy expenditure in rats (Rothwell
and Stock, 1984).
In summary, within the mammalian metabolic-hormonal
network, our studies establish the HPA/liver GR axis as a primary
checkpoint in the regulation of systemic BA homeostasis.
EXPERIMENTAL PROCEDURES
Full details of all methods are in the Supplemental Information.
Recombinant Viruses
Adenoviruses expressing GR-specific, Ntcp-specific, or nonspecific negative
control shRNA under control of the U6 promoter were cloned as described
previously (Lemke et al., 2008).
For long-term inactivation of GR, adeno-associated viruses (AAV) encoding
GR-specific miRNA driven by a hepatocyte-specific promoter (Nathwani et al.,
2006) were established according to published methods (Wang et al.,
2003). Recombinant viruses were produced in 293T cells through triple
Cell Metabolism
Hepatic GR Controls Bile Acid Homeostasiscotransfection of the recombinant viral backbone vector with the pDGDVP
helper plasmid (Grimm et al., 1998) and a mutated p5E18-VD2/8 expression
vector (Gao et al., 2002) encoding AAV2 rep and a mutated AAV8 cap protein.
Animal Experiments
Mice used were male C57BL/6J (Charles River Laboratories, Brussels, BEL),
C57L/J (Jackson Laboratory, Bar Harbor, ME, USA), GRdim/dim (Reichardt
et al., 1998), and GRAlfpCre (Opherk et al., 2004). Mice were fed a standard
control diet (Research Diets D12102C, New Brunswick, NJ, USA) or a litho-
genic diet (i.e. 1.25% cholesterol + 0.5% Na+-cholate; D12105C). Animal
experiments were conducted according to local, national, and EU ethical
guidelines.
Human Experiments
Serum samples were obtained from patients with Addison’s disease after
acute withdrawal from glucocorticoid treatment as well as carefully matched
control subjects before and after meal feeding as outlined in detail (Klement
et al., 2010).
Serum, Bile, and Tissue Metabolite; ALT; and Corticosterone
Analyses
Frozen liver samples were pulverized, weighed, and extracted. Commercial
kits were used to quantify serum, bile, and tissue concentrations of metabo-
lites/enzymes/hormones. Lipid and bile acid analyses were conducted
according to established guidelines (Argmann et al., 2006). Values were
calculated as molar concentration per liter (serum and bile) or gram wet tissue
(liver and intestine).
Gallbladder Bile Analyses
Bile cholesterol saturation index (CSI) was calculated based upon critical
tables (Carey and Small, 1978). For determination of the presence of
gallstones, intact gallbladders were carefully examined above light prior to
puncture. For determination of crystals in gallbladder bile, 1mL of bile was
examined using polarizing light microscopy, and the total number of visible
crystals was determined based upon known structures (Wang and
Carey, 1996).
RNA/Protein Extraction and Analysis
RNA was extracted from tissue and cells and cDNA from this was analyzed
using standard techniques. Tissue protein extraction and immunoblotting
was performed according to published methods (Rose et al., 2007).
In Vitro and Ex Vivo Bile Acid Uptake/Transport
In vitro taurocholate transport was determined from isolated liver membrane
vesicles as described (Boyer andMeier, 1990). For ex vivo taurocholate uptake
studies of liver slices we modified a method used for isolated rat liver cells
(Blitzer et al., 1982; Schwarz et al., 1975).
Avidin Biotin Complex DNA (ABCD) Assay
Assays were conducted as described previously (Wu, 2006).
Chromatin Immunoprecipitation (ChIP) Assay
ChIP analyses were performed from frozen liver powder and conducted as
described (Hecht and Grunstein, 1999). ChIP data are expressed as a ratio
of relative enrichment versus nonspecific IgG normalized to input DNA or as
percentage input (Chakrabarti et al., 2002).
Statistical Analyses
For one-factorial designs, two-tailed unpaired t tests were performed. For
multiple comparisons statistical analyses were performed using a two-way
analysis of variance (ANOVA) with Holm-Sidak posthoc tests when significant
differences were detected. For analysis of relationships between variance of
multiple variables within a subject, correlation and regression analyses were
performed. The significance level was set at p < 0.05.SUPPLEMENTAL INFORMATION
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